Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-91
Closed -$2K 274
2022
Q3
$2K Hold
91
﹤0.01% 334
2022
Q2
$4K Hold
91
﹤0.01% 314
2022
Q1
$4K Hold
91
﹤0.01% 158
2021
Q4
$5K Buy
+91
New +$4.73K ﹤0.01% 157
2021
Q3
Sell
-91
Closed -$4K 64
2021
Q2
$4K Hold
91
﹤0.01% 111
2021
Q1
$4K Hold
91
﹤0.01% 138
2020
Q4
$4K Buy
+91
New +$4.18K ﹤0.01% 125

Other funds holding GSK

Mach-1 Financial Group's GSK Position: Q4 2022 in Review

Mach-1 Financial Group sold out of GSK (GSK) in Q4 2022, closing a stake of 91 shares — an estimated $2K sold.

Mach-1 Financial Group first reported a position in GSK in Q4 2020 and held it in 7 quarters. The position peaked at $5K in Q4 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Mach-1 Financial Group reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Mach-1 Financial Group sold 91 GSK shares in Q4 2022, an estimated $2K.
  • Mach-1 Financial Group first reported a position in GSK in Q4 2020 and held it in 7 quarters.
  • Mach-1 Financial Group's GSK position peaked at $5K in Q4 2021.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Mach-1 Financial Group's 13F filing for Q4 2022, filed 2 Feb 2023.